Integra Interest Coverage from 2010 to 2024
| IART Stock | USD 31.63 0.31 0.97% |
Interest Coverage | First Reported 2010-12-31 | Previous Quarter 2.42337677 | Current Value 1.42 | Quarterly Volatility 2.48628926 |
Check Integra LifeSciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Integra main balance sheet or income statement drivers, such as Depreciation And Amortization of 129.7 M, Interest Expense of 75.4 M or Total Revenue of 1.6 B, as well as many exotic indicators such as Price To Sales Ratio of 4.18, Dividend Yield of 0.43 or PTB Ratio of 3.53. Integra financial statements analysis is a perfect complement when working with Integra LifeSciences Valuation or Volatility modules.
Integra | Interest Coverage |
Latest Integra LifeSciences' Interest Coverage Growth Pattern
Below is the plot of the Interest Coverage of Integra LifeSciences Holdings over the last few years. It is Integra LifeSciences' Interest Coverage historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Integra LifeSciences' overall financial position and show how it may be relating to other accounts over time.
| Interest Coverage | 10 Years Trend |
|
Interest Coverage |
| Timeline |
Integra Interest Coverage Regression Statistics
| Arithmetic Mean | 2.10 | |
| Geometric Mean | 2.32 | |
| Coefficient Of Variation | 118.66 | |
| Mean Deviation | 1.58 | |
| Median | 2.42 | |
| Standard Deviation | 2.49 | |
| Sample Variance | 6.18 | |
| Range | 10.349 | |
| R-Value | 0.45 | |
| Mean Square Error | 5.32 | |
| R-Squared | 0.20 | |
| Significance | 0.09 | |
| Slope | 0.25 | |
| Total Sum of Squares | 86.54 |
Integra Interest Coverage History
About Integra LifeSciences Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Integra LifeSciences income statement, its balance sheet, and the statement of cash flows. Integra LifeSciences investors use historical funamental indicators, such as Integra LifeSciences's Interest Coverage, to determine how well the company is positioned to perform in the future. Although Integra LifeSciences investors may use each financial statement separately, they are all related. The changes in Integra LifeSciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Integra LifeSciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Integra LifeSciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Integra LifeSciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Interest Coverage | 2.42 | 1.42 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Integra LifeSciences Correlation against competitors. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Integra Stock analysis
When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |
Is Integra LifeSciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Integra LifeSciences. If investors know Integra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Integra LifeSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.60) | Earnings Share 0.84 | Revenue Per Share 19.248 | Quarterly Revenue Growth (0) | Return On Assets 0.0424 |
The market value of Integra LifeSciences is measured differently than its book value, which is the value of Integra that is recorded on the company's balance sheet. Investors also form their own opinion of Integra LifeSciences' value that differs from its market value or its book value, called intrinsic value, which is Integra LifeSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Integra LifeSciences' market value can be influenced by many factors that don't directly affect Integra LifeSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Integra LifeSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Integra LifeSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Integra LifeSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.